<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-129375</identifier>
<setSpec>1695-4033</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Tuberous sclerosis: Clinical characteristics and their relationship to genotype/phenotype</dc:title>
<dc:description xml:lang="en">Introduction: Tuberous sclerosis (TS) is an inherited disorder with multisystemic involvement and a high phenotypic variability. There are two genes that cause this condition: TSC1 and TSC2. Objectives: Our goal was to clinically characterize patients with TS followed up in the Pediatric Neurology Clinic of a tertiary hospital during the last 10 years, and correlate the genotype with the severity of neurological manifestations and imaging studies. Patients and methods: Retrospective analysis of patients with TS, including review of medical records and available MRI imaging. Results: We studied 35 cases with a median age at diagnosis of ten months. Seizures were the first manifestation in 91.4% of cases, with a predominance of epileptic spasms. Over 50% had cognitive impairment and 49% behavioral disorders. A genetic study was performed on 24 children, and TSC2 mutations identified in 58.3% of them. Of the 11 cases of refractory epilepsy, six had the TSC2 gene mutation. In the group of eight patients with moderate/severe cognitive deficits, five had TSC2 mutations. We reviewed 26 MRI scans, in which it was observed that 76.9% had diffuse involvement of cerebral lobes, which reflects a greater burden of injury. Of the patients who had an MRI scan performed and had TSC2 mutations, all had a high tuber load, and5 of them had refractory epilepsy. Discussion: In our sample we observe a high percentage of mutations in the TSC2 gene. This mutation carries a worse neurological prognosis, with drug-resistant epilepsy and a more severe cognitive impairme (AU)</dc:description>
<dc:creator>Chorao, R</dc:creator>
<dc:creator>Temudo, T</dc:creator>
<dc:creator>Santos, M</dc:creator>
<dc:creator>Pina, S</dc:creator>
<dc:creator>Carrilho, I</dc:creator>
<dc:creator>Monteiro, T</dc:creator>
<dc:creator>Figueiroa, S</dc:creator>
<dc:creator>Garrido, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: La esclerosis tuberosa (ET) es una enfermedad de afectación multisistémica y gran variabilidad fenotípica. Están identificados 2 genes involved en la génesis de la enfermedad: TSC1 y TSC2. Objetivos: Caracterizar clínicamente a los pacientes con ET seguidos en Neurología Pediátrica de un hospital de tercer nivel durante los últimos 10 años y correlacionar el genotipo con la gravedad de la clínica neurológica y los estudios de imagen. Pacientes y métodos: Estudio retrospectivo descriptivo, mediante consulta de la historia clínica y evaluación de las resonancias magnéticas (RM) de pacientes con ET. Resultados: Se estudiaron 35 casos, con una mediana de edad, al diagnóstico, de 10 meses. En el 91,4% se registraron crisis epilépticas, con un predominio de espasmos epilépticos a la presentación. Más del 50% tenía deterioro cognitivo y el 49% trastornos de conducta. Se sometieron a estudio genético 24 ni&#152;nos con predominio de mutaciones TSC2 (58,3%). De los 11 casos de epilepsia refractaria, 6 tenían mutación del gen TSC2. De los 8 pacientes con déficit cognitivo moderado a grave, se identificaron 5 mutaciones TSC2. Se revisaron 26 RM y en el 76,9% se observó una afectación completa de los lóbulos cerebrales, lo que refleja una gran cantidad de lesiones. De los enfermos con mutaciones TSC2 y RM realizada, todos tenían alta carga de lesión y 5 epilepsia refractaria. Discusión: En nuestra muestra, nos encontramos con un alto porcentaje de mutaciones en el gen TSC2. Esta mutación está asociada a un peor pronóstico neurológico, con crisis más farmacorresistentes y un atraso cognitivo más severo (AU)</dc:description>
<dc:source>An Pediatr (Barc);81(5): 289-296, nov. 2014. tab, ilus</dc:source>
<dc:identifier>ibc-129375</dc:identifier>
<dc:title xml:lang="es">Esclerosis tuberosa: caracterización clínica e intento de correlación fenotipo/genotipo</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d33525^s22080</dc:subject>
<dc:subject>^d3103^s22080</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d10833</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d4907^s22080</dc:subject>
<dc:subject>^d5974</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9346^s22033</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d14804^s22032</dc:subject>
<dc:subject>^d32271</dc:subject>
<dc:subject>^d23405</dc:subject>
<dc:type>article</dc:type>
<dc:date>201411</dc:date>
</metadata>
</record>
</ibecs-document>
